Hot Topics - Hypertrophic cardiomyopathy, sudden death, and implantable defibrillators

Steve R. Ommen, M.D., director, Hypertrophic Cardiomyopathy Clinic at Mayo Clinic, reviews risk factors for sudden cardiac death in patients with hypertrophic cardiomyopathy. He introduces two risk factor identification tools appropriate for reviewing risk. Dr. Ommen emphasizes the importance of discussing implantable cardiac defibrillators in patients with hypertrophic cardiomyopathy, including risks for implantation. 

If you are interested in an online community for patients, families and friends of those with heart disease, click here.

If you are a medical professional and would like to connect with a Mayo Clinic physician, click here.

 

Related Presenters

Steve R. Ommen, MD.

Steve R. Ommen, MD

Conditions treated Heart valve disease Hypertrophic cardiomyopathy Procedures performed Echocardiogram Interests Hypertrophic cardiomyopathy Valvular heart disease Echocardiography Cardiovascular hemodynamics Education

View full profile

Related Videos